Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Burning Rock Biotech (BNR) Inventory Average (2020 - 2025)

Historic Inventory Average for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to $7.9 million.

  • Burning Rock Biotech's Inventory Average fell 1513.17% to $7.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.9 million, marking a year-over-year decrease of 1513.17%. This contributed to the annual value of $9.2 million for FY2024, which is 3604.63% down from last year.
  • Latest data reveals that Burning Rock Biotech reported Inventory Average of $7.9 million as of Q3 2025, which was down 1513.17% from $8.5 million recorded in Q2 2025.
  • Burning Rock Biotech's Inventory Average's 5-year high stood at $20.3 million during Q3 2022, with a 5-year trough of $7.9 million in Q3 2025.
  • Over the past 5 years, Burning Rock Biotech's median Inventory Average value was $12.7 million (recorded in 2021), while the average stood at $13.3 million.
  • As far as peak fluctuations go, Burning Rock Biotech's Inventory Average skyrocketed by 8011.81% in 2021, and later crashed by 4796.08% in 2024.
  • Over the past 5 years, Burning Rock Biotech's Inventory Average (Quarter) stood at $17.8 million in 2021, then grew by 12.18% to $20.0 million in 2022, then plummeted by 46.11% to $10.8 million in 2023, then dropped by 16.37% to $9.0 million in 2024, then dropped by 12.89% to $7.9 million in 2025.
  • Its Inventory Average was $7.9 million in Q3 2025, compared to $8.5 million in Q2 2025 and $8.8 million in Q1 2025.